[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.159.158.180. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Article
May 1983

Metastatic Uveal MelanomaHepatic Cell-Surface Enzymes, Isoenzymes, and Serum Sialic Acid Levels in Early Metastatic Disease

Author Affiliations

From the Department of Clinical Research, the Retina and Oncology Services (Drs Donoso, Brockman, Augsburger, and Shields) and the Department of Immunology (Ms Nagy), Wills Eye Hospital, and Thomas Jefferson University and the American Oncologic Hospital (Drs Berd and Mastrangelo), Philadelphia.

Arch Ophthalmol. 1983;101(5):791-794. doi:10.1001/archopht.1983.01040010791020
Abstract

• Serum hepatic cell-surface enzymes, isoenzymes, and sialic acid levels may be useful adjuncts in detecting early metastatic disease and in evaluating the tumor burden of patients with uveal melanoma. Hepatic cell-surface enzyme concentrations were elevated in the serum of ten patients with uveal melanoma and liver metastasis and in five patients with other hepatobiliary disorders and in 75 control patients. Five patients in the metastatic group (50%) had serum γ-glutamyl transpeptidase and 5′-nucleotide phosphodiesterase (5-NPD) bands known to be associated with either primary hepatic carcinoma or carcinoma metastatic to the liver. One patient with uveal melanoma without known metastasis had a positive 5-NPD pattern; metastatic disease was subsequently proved. Higher levels of sialic acid were found in the serum of patients with uveal melanoma and metastatic disease (4 μmole/mL) than in controls (2.4 μmole/mL).

×